Luye Pharma Group Ltd.
LYPHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $839 | $700 | $670 | -$75 |
| Dep. & Amort. | $791 | $702 | $671 | $582 |
| Deferred Tax | $0 | $0 | $0 | -$312 |
| Stock-Based Comp. | $21 | $21 | $25 | $50 |
| Change in WC | -$1,234 | $398 | $320 | -$418 |
| Other Non-Cash | -$250 | -$225 | -$33 | $355 |
| Operating Cash Flow | $168 | $1,595 | $1,654 | $182 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$596 | -$633 | -$1,164 | -$1,542 |
| Net Acquisitions | -$634 | -$1,380 | $0 | -$809 |
| Inv. Purchases | -$2,390 | -$1,628 | -$3,486 | -$3,976 |
| Inv. Sales/Matur. | $3,561 | $2,593 | $2,899 | $1,919 |
| Other Inv. Act. | -$1,412 | -$371 | $92 | $971 |
| Investing Cash Flow | -$1,471 | -$1,418 | -$1,658 | -$3,436 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $1,876 | -$478 | -$666 | -$406 |
| Stock Issued | $0 | $923 | $189 | $1,044 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,080 | $397 | $531 | $1,241 |
| Financing Cash Flow | $2,956 | $842 | $54 | $1,879 |
| Forex Effect | $45 | -$104 | -$164 | -$52 |
| Net Chg. in Cash | $1,698 | $915 | -$115 | -$1,427 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $3,239 | $2,324 | $2,438 | $3,865 |
| End Cash | $4,937 | $3,239 | $2,324 | $2,438 |
| Free Cash Flow | -$1,541 | $430 | $490 | -$1,359 |